Drug details
Eucrisa Ointment (crisaborole)
type of PDE-4 Inhibitors, Topical
Eucrisa (crisaborole) ointment, 2%, for topical use is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.
This drug may have the following side effects:
- hives,
- itching,
- swelling,
- severe dizziness, and
- trouble breathing
- redness,
The following drugs are related to Eucrisa Ointment, either as a replacement or used together:
- Adbry (tralokinumab-ldrm for injection)
- Airsupra (albuterol and budesonide inhalation aerosol, for oral inhalation)
- Zithranol Cream (anthralin microcrystalline encapsulated cream)
- Avage (tazarotene)
- Beser (fluticasone propionate lotion)
- Bryhali (halobetasol propionate lotion)
- Cordran Cream (clurandrenolide cream)
- Cordran Lotion (flurandrenolide lotion)
- Cordran Tape (flurandrenolide tape)
- Sotyktu (deucravacitinib tablets)
- Duobrii (halobetasol propionate and tazarotene lotion)
- Elidel (pimecrolimus cream)
- Ellzia Pak (triamcinolone acetonide ointment)
- Ultravate Ointment (halobetasol propionate ointment)
- MiCort HC (hydrocortisone acetate cream)
- Pandel (hydrocortisone probutate cream)
- Opzelura (ruxolitinib cream)
- Protopic (tacrolimus)
- Renova (tretinoin emollient cream 0.05%)
- Renova 0.02% (tretinoin cream)
- Retin-A (tretinoin)
- Retin-A Micro (tretinoin gel)
- Skyrizi (risankizumab-rzaa injection)
- Tezspire (tezepelumab-ekko injection, for subcutaneous use)